ArticleiGIE : innovation, investigation and insights2024
EUS-based shear wave elastography of the spleen for detection of clinically significant portal hypertension.
Article in iGIE : innovation, investigation and insights, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications.World journal of gastroenterology · 2025Review
- Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review.World journal of hepatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: A measurement of spleen stiffness has been demonstrated to improve the detection of clinically significant portal hypertension (CSPH). In this study, we evaluated the performance of EUS-guided shear wave elastography (EUS-SWE) for detecting CSPH. Methods: EUS-SWE measurements of the spleen were compared between patients with and without CSPH. Receiver-operating characteristic curve analysis was performed and quantified by the area under the receiver-operating characteristic curve (AUROC). Results: Of 142 patients with EUS-SWE spleen measurements, 13 (9.2%) had CSPH and 129 (90.8%) did not. Patients with CSPH had a significantly higher mean spleen stiffness (37.6 ± 8.5 kPA vs 29.1 ± 9.9 kPA, Conclusions: SWE is a promising technology that can readily be incorporated into standard EUS examination for assessment of portal hypertension.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.